Abstract The purpose of this study was to determine the effects of the vasoactive perivascular neuropeptide substance P (SP) on the growth and function of vascular endothelial cells in serum-free culture conditions with cells quiescent in the GO-G, phase of the cell cycle and to characterize the response. In addition, interactions between SP and other growth factors and neuropeptides including insulin, platelet factors, neurokinin A, neurokinin B, and calcitonin gene-related peptide (CGRP) were studied on endothelial cell growth and compared. Growth effects were determined by stimulation of tritiated thymidine incorporation into DNA and cell proliferation. SP exhibited differential effects on cell growth that were a function of concentration, incubation time, interaction with other growth factors, and cell culture conditions. DNA synthesis in response to SP showed a bell-shaped distribution with a maximal effect that was 10.5-fold over control at 500 ,ug/mL of SP after 48 hours of incubation. The effect showed marked synergism with insulin (10 ,ug/mL) and with CGRP (0.01 to 10 ,ug/mL), which is colocalized with SP in vivo. Insulin and CGRP alone had no significant effect on endothelial cell growth. Furthermore, no synergism was observed between SP and platelet-derived growth factor or platelet-derived endothelial cell growth factor. Endothelial cell proliferation increased in response to SP to 2.6-fold over control at 48 hours, was maximal at 10 ,tg/mL SP, and also demonstrated synergism with insulin (10 ,ug/mL). Our studies indicate that neuropeptides play a significant role in regulating endothelial cell growth and proliferation. The demonstrated synergism between SP and other known growth factors and neuropeptides implies that synergism between differing signal transduction pathways may be significant in the total observed response. These findings suggest that SP may have an important role in the normal and pathophysiological states of the vasculature. (Circ Res. 1994;75:1113-1120 Key Words * substance P * neuropeptides * cell growth * endothelial cell * tachykinins T he vascular endothelium is strategically poised between blood and the subendothelial layers of the vascular wall. The endothelium consists of a quiescent contact-inhibited cell monolayer seemingly structurally simple but functionally complex and participates in a variety of cellular events, including the elaboration of growth factors and regulation of vascular cell growth.' In addition, the endothelium is important in pathophysiological events, including atherogenesis and wound healing.' Substance P (SP) is a ubiquitous vasoactive perivascular member of the tachykinin family of neuropeptides, which share a common carboxy-terminal sequence and include the structural analogues neurokinin A (NK-A) and neurokinin B (NK-B). SP is present in capsaicin-sensitive unmyelinated primary afferent nerve fibers in peripheral organs and envelops the vasculature, with the highest density of SP-containing networks concentrated in the aorta and venae cavae close to the heart.2 SP has also been localized in the adventitia and the medial-adventitial border of the vessel wall and is synthesized and released from arterial endothelial cells (ECs),3-6 where it has been localized to the cytoplasm.5 SP is colocalized in vascular
T he vascular endothelium is strategically poised between blood and the subendothelial layers of the vascular wall. The endothelium consists of a quiescent contact-inhibited cell monolayer seemingly structurally simple but functionally complex and participates in a variety of cellular events, including the elaboration of growth factors and regulation of vascular cell growth.' In addition, the endothelium is important in pathophysiological events, including atherogenesis and wound healing. ' Substance P (SP) is a ubiquitous vasoactive perivascular member of the tachykinin family of neuropeptides, which share a common carboxy-terminal sequence and include the structural analogues neurokinin A (NK-A) and neurokinin B (NK-B). SP is present in capsaicin-sensitive unmyelinated primary afferent nerve fibers in peripheral organs and envelops the vasculature, with the highest density of SP-containing networks concentrated in the aorta and venae cavae close to the heart.2 SP has also been localized in the adventitia and the medial-adventitial border of the vessel wall and is synthesized and released from arterial endothelial cells (ECs), [3] [4] [5] [6] where it has been localized to the cytoplasm.5 SP is colocalized in vascular afferent nerve endings with calcitonin gene-related peptide (CGRP), where it has a role as a mediator of neurotransmission, neurotropism, and neurogenic inflammation.5'7-10 SP is also present in the blood of humans and other mammals and can be detected in plasma by radioimmunoassay,1" with increased plasma levels reported in conditions characterized by uncontrolled cellular growth, including malignancies.12"13 A variety of circulatory and vascular effects of SP have been elucidated or postulated. These effects include its role in stimulating immune function,14 tissue repair,15 increased vascular permeability,16"17 response to hypoxia3 and its role as a mediator of inflammation,18 potent peripheral and coronary vasodilator, and modulator of coronary blood flow. [19] [20] [21] [22] The two latter effects are associated with SP-mediated endothelial prostacyclin (PGI2) production23'24 and endothelium-dependent production of endothelium-derived relaxing factor (EDRF). 25, 26 Evidence from recent studies27-29 suggests that sensory neuropeptides may also play an important role in regulating in vitro cellular proliferation. However, the role of SP on arterial endothelial cell growth is unknown. We hypothesized that SP is a stimulus for arterial EC growth. The purpose of the present study was to use a serum-free culture environment with cells in growth quiescence to determine the role of SP on EC growth, to compare the response with that of other neuropeptides to include NK-A, NK-B, and CGRP, and to characterize the growth response by evaluating the modulating effects of known growth factors and blood elements, including insulin, serum, and platelet-poor plasma. Growth-promoting cellular responses were studied by determining incorporation of [3H]thymidine into DNA and by cell counts.
Materials and Methods Materials Chemicals
SP was obtained from Sigma Chemical Co. Aqueous solutions of SP were found to be unstable with repeated freezethawing but could be kept at 5°C for up to 1 week with loss of half of the maximal activity. All solutions were made up fresh before their use. SP was determined to be >99% pure by high-performance liquid chromatography (HPLC) done in our laboratory on the purchased peptide. Norleucine SP (NL-SP) was obtained from Multiple Peptide Systems. Human CGRP, NK-B, SP fragments 1-9, 5-11, and 6-11, bovine insulin, and hydroxyurea were purchased from Sigma; NK-A was from Peptide Institute Inc; [3H]thymidine was obtained from Amersham; and the metalloendopeptidase enkephalinase (EK) was acquired from Genentech Inc and was stable in 0.15 mol/L NaCl in 0.01 mol/L HEPES (pH 7.2) at 5°C for over 1 year. Platelet-derived growth factor (PDGF, human AB) was purchased from JR Scientific. Platelet-derived EC growth factor (PD-ECGF) was prepared from the plasma fraction of human platelets30 and partially purified (=50%) by CM and QAESephadex chromatography and ammonium sulfate precipitation as described previously.31 This material stimulated EC DNA synthesis threefold to fourfold over control at dilutions of up to 1:125.
Tissue Culture Supplies
Medium 199 was purchased from Fisher; fetal bovine and iron-supplemented calf serum were from Hyclone; penicillin/ streptomycin/fungizone, trypsin, thymidine, and EDTA were obtained from Sigma; tissue culture plates were from Falcon; tissue culture flasks were from Corning Glass Works; and cell scrapers were from Costar.
Cell Culture
Secondary cultures of calf pulmonary artery ECs were obtained from the American Type Culture Collection (CRL 1733) and as a generous gift from Una Ryan, St Louis, Mo. Cells were routinely cultured in medium 199 supplemented with 5% fetal bovine serum, 5% iron-supplemented calf serum, and 10`mol/L thymidine, hereafter referred to as growth medium, plus antibiotics (100 U/mL penicillin, 0.1 mg/mL streptomycin, and 0.25 ,ug/mL amphotericin B) on plastic tissue-culture flasks in a humidified atmosphere of 5% CO2 and air at 37°C. Cells were passaged weekly nonenzymatically at a split ratio of 1:2 by using a cell scraper and were subcultured an average of three or four times (range, 1 to 10 times) after they were received before being used for studies. No differences were seen in the cellular responses to neuropeptides and growth factors for the range of subcultures used.
DNA Synthesis Assay
To perform accurate counts for plating, ECs were removed from the tissue culture flasks by incubating them for 2 minutes at 37°C with 0.25% trypsin in EDTA (25 mmol/L in 50 mmol/L NaCl, pH 7.4) and then plated in the inner 60 wells of 96-well plastic plates at a density of 6 x103 cells per well in serumcontaining growth medium. The outer 36 wells were rimmed with sterile water. Two days later the cells were fed with fresh growth medium devoid of thymidine and allowed to deplete this medium for an additional 2 days, at which point the cells 
Results

DNA Synthesis and Cell Proliferation
An increase in DNA synthesis was observed in rewere preconfluent (40% to 60% confluent) and still relatively sponse to SP in concentrations ranging from 50 to 1000 ,ug/mL (molecular weight, 1348). The response displayed a bell-shaped distribution with SP concentrations <10 ,ug/mL or >1000 ,ug/mL not differing significantly from serum-free medium 199 (blank). The response was significant and 2.4-fold greater than blank (1694±212 versus 720±174 cpm, P<.05) starting at 50 ,ug/mL of SP and 10.5-fold greater than blank and maximal at 500 ,ug/mL of SP (7581±543 versus 720±174 cpm, P<.001). The maximal response corresponded to a 953% increase in DNA synthesis over blank at 48 hours, with no further increases seen with longer incubation times of up to 6 days. Because 150 ,ug/mL was a concentration of SP that was consistently and predictably associated with a greater than twofold increase in DNA synthesis, this concentration of SP was used for many of the subsequent studies.
To evaluate whether DNA synthesis in response to SP was reparative (as might occur in response to SPinduced DNA injury) or de novo (as would occur in mitogenesis), cells were incubated with SP in the presence of hydroxyurea, which blocks the transition between the G, and S phases of the cell cycle by interfering with dATP production33 and therefore inhibits scheduled DNA synthesis. As shown in Fig 1, hydroxyurea (1 mmol/L) completely abolished the SP-induced increase in DNA synthesis, indicating that DNA synthesis in response to SP was not due to SP-induced DNA injury and subsequent DNA repair but represented de novo DNA synthesis.
To determine if the SP-stimulated increase in DNA synthesis was accompanied by and reflective of cellular proliferation, cell counts were performed after ECs were incubated with SP for 48 hours to 6 days. As is shown in Fig 2, SP protection against cell death during the step-down procedure but not reflective of proliferation.
To further characterize EC growth in response to SP and evaluate the interaction(s) between SP and other known growth factors, ECs were incubated with SP and insulin, PDGF, or PD-ECGF. Insulin (10 ,ug/mL, 10`6 mol/L) showed a synergistic response with SP on DNA synthesis. This response was seen at SP concentrations as low as 10 ,ug/mL, and the magnitude of the response increased as the SP concentration increased. Fig 3  demonstrates 50 ,ug/mL, respectively). DNA synthesis studies were also performed with coincubations of SP and PDGF (human AB, 50 ,ug/mL) and SP and PD-ECGF (1:125 dilution of partially purified material as described in "Materials and Methods"), and in contrast to insulin, these peptides in combination with SP had effects that did not differ from those of SP alone (data not shown). Therefore, no synergism was observed between these platelet factors and SP on DNA synthesis stimulation.
To study the interactions of SP with other neuropeptides that colocalize with SP in vivo, SP was incubated with varying concentrations of CGRP (0.01 to 10 gg/ mL; molecular weight, 3789) (Fig 4) . Although CGRP at 0.01, 0.1, 1.0, and 10 ,ug/mL stimulated DNA synthesis 15%, 40%, 21%, and 18% above blank, respectively, these effects were negligible when compared with even the smallest EC response to SP (50 ,ug/mL), which represented an increase in DNA synthesis that was 223% over blank (1634±104 versus 506±47 cpm, P<.001). However, as shown in Fig 4, there was marked synergism between SP and CGRP. The synergistic effect of SP (150 ,ug/mL) and CGRP (10 ,g/mL) was twofold greater than the effect of SP alone on DNA synthesis (3336±74 versus 1634±104 cpm, P<.001). In addition, as demonstrated in Fig 5, CGRP further enhanced the previously described (Figs 2 and 3 ) synergistic response between insulin and SP. The effect of the synergistic response between insulin (10 ,g/mL), SP (150 ,ug/mL), and CGRP (10 ,ug/mL) was 1. To further characterize the response to SP, to demonstrate that the effects were not due to an impurity in the SP preparation, and to determine the components of the peptide needed for its activity, cells were incubated with SP in the presence of the metalloendopeptidase EK. We first carried out HPLC analysis of the peptide fragments generated by treatment of SP with EK. This analysis confirmed that EK cleaved SP by hydrolysis of peptide bonds at the amino side of hydrophobic residues, thereby cleaving SP between amino acid residues 6-7, 7-8, and 9-10. Our results are in agreement with the known effect of EK as reported in Reference 34. For the EK experiments, cells were plated and brought to growth quiescence as described in "Materials and Methods." The conditioned medium was removed from the wells, and the wells were washed three times with sterile phosphate-buffered saline. Cells were then incubated for 48 hours in serum-free medium 199, to which EK and the desired concentration(s) of SP had been freshly added. Our results demonstrated that in the presence of EK (10 ,g/mL) the ability of SP to stimulate DNA synthesis was entirely abolished (Fig 6) . The effect was unchanged by the addition of insulin, and EK had no effect on insulin alone (data not shown). Similar results were obtained when SP was inactivated by incubating it with EK for 1 hour before adding SP to the cells, indicating that the effect of EK on the ability of SP to stimulate DNA synthesis was not due to a nonspecific action of EK on the cells but rather to enzymatic cleavage of SP by EK. In addition, to determine whether SP amino acid residue fragments, other than those generated by EK, might possess growthpromoting activity and have physiological mitogenic importance, in a separate series of experiments, cells were incubated with commercially obtained SP amino acid fragments 1-9, 5-11, and 6-11 in concentrations ranging from 10 to 150 ,g/mL. These fragments were chosen because they contain elements from both the NH2 and COOH terminals of SP. Our results again indicated that in contrast to SP, these SP fragments did 10 ,ug/mL. Spantide alone had no significant effect on EC growth over a wide concentration range (0.1 to 50 ,ug/mL) but was somewhat inhibitory at higher concentrations (150 ,ug/mL, 1.01 X 10`4 mol/L).
Discussion
The results of the present study demonstrate that SP has marked stimulatory effects on DNA synthesis and nroliferation in arowth-arrested arterial ECs in serumfree culture and that the effects are dependent on incubation time and SP concentration. In addition, we have demonstrated for the first time synergism between SP and insulin, between two neuropeptides (SP and CGRP), and between three growth factors (SP, insulin, and CGRP) in the EC mitogenic response. The respective synergistic effects were 2.1-, 2.0-, and 3.7-fold greater than the response to SP alone. The maximal response to SP alone was 10.5 -fold greater than control. The results presented herein constitute previously undescribed evidence for growth-promoting effects of SP on arterial (pulmonary artery) ECs and will be discussed in terms of the findings of previous studies and the possible role of synergistic signal transduction mechanisms in mediating neuropeptide-stimulated cell growth.
Our results are in agreement with those of previous investigators who have demonstrated mitogenic effects of SP on various nonvascular cell types13,273536 and on adrenal microvascular endothelial cells.37 However, the mitogenic effects for SP reported in these studies are at SP concentrations ranging from 10-10 to 10-8mol/L. The differences between our results, which showed that higher concentrations of SP (10`to 10`mol/L) were needed for a growth-stimulating response, and those of these investigators is largely attributable to differences in the cell types used and to the different study conditions used. Previous investigators have used proliferating cells with growth factors added in the presence of bovine serum albumin and/or calf serum compared with the conditions used in the present study, which consisted of growth-quiescent cells in serum-free medium. The important roll played by culture conditions is suggested by our data (not shown), which demonstrated that serum and platelet-poor plasma modulated and enhanced the effect of SP (with a significant proliferative effect observed at 10-7 mol/L SP), demonstrating synergism between SP and serum and plasma factors.
However, the study of ECs arrested in the GO-G, phase of the cell cycle and in the absence of platelets and growth factors contained in serum constitutes a more suitable environment for the study of EC growth responses and is more physiological, because endothelium in vivo is in growth quiescence and undergoes <0.1% turnover per day and is not normally exposed to serum, except at wound sites.32 In addition to the role of culture conditions, the present study indicates that although a lower concentration of SP may be sufficient to stimulate DNA synthesis in proliferating cells, a higher concentration is necessary to stimulate DNA synthesis in quiescent cells. It is important to also note that although the plasma concentration at which SP can be detected in blood is several orders of magnitude smaller than the concentrations required to stimulate calf pulmonary artery EC proliferation in the present study, ECs in vivo may be exposed to higher local concentrations of SP since three sources of SP are locally available to ECs: SP released from perivascular peripheral afferent nerve endings,2 circulating Sp,38 and SP released from ECs themselves. 3 The functional and growth-promoting effects of SP on arterial ECs do not appear to be attributable to other members of the tachykinin family to which SP is structurally related or to physiologically active fragments but rather to actions of the intact peptide. In contrast to SP, our studies with other members of the tachykinin family, NK-A and NK-B, which can colocalize with SP (NK-A)39 and be released from sensory nerve terminals,40 demonstrated no effect on EC growth and no synergism with insulin. Similar results have been obtained by others,41 who have reported that NK-A lacks growth-stimulatory activity on human umbilical vein ECs. These findings may be explainable by the available data regarding tachykinin receptor interactions, which suggest that ECs may lack NK-2 and NK-3 receptors but have NK-1 receptors.264042 These receptor subtypes are believed to possess relative ligand specificity for NK-A, NK-B, and SP, respectively. 37, 40 In this regard, our results with spantide, an NK-1 receptor antagonist, which inhibited in a dose-dependent manner SP-stimulated DNA synthesis, strongly suggest that SP-mediated endothelial mitogenic effects are NK-1 receptor-mediated.
Our studies performed with combinations of SP and other growth factors have revealed an important aspect of their action -the existence of synergistic interactions. These interactions were exemplified by our results demonstrating that insulin alone showed no effect on DNA synthesis but markedly synergized with SP: the synergistic effect was seen at lower SP concentrations (10 ig/mL) than observed for the initiation of DNA synthesis in response to SP alone (50 ,ug/mL). These data suggest that SP may play the most significant role in EC growth under conditions that more closely approximate the physiological environment of the ECs or conditions that may be found at sites of injury. In addition, our results suggest that the mitogenic effect of SP on ECs may not be evident under all in vitro culture conditions and that certain factors (eg, insulin, serum, plasma) may be important for eliciting the complete set of events leading to a growth response, possibly by modulating SP NK-1 receptor expression, the affinity of SP for its receptor, interactions with lower affinity NK-1 receptor subtypes,43 '44 
